104
Bioinformatics of the Brain
[100] G. P. Cribaro, E. Saavedra-López, and L. Romarate et al., “Three-
dimensional vascular microenvironment landscape in human glioblas-
toma,” Acta Neuropathologica Communications, vol. 9, no. 1, p. 24, 2021.
[101] T. Sun, R. Patil, and A. Galstyan et al., “Blockade of a laminin-411–
Notch axis with CRISPR/Cas9 or a nanobioconjugate inhibits glioblas-
toma growth through tumor-microenvironment cross-talk,” Cancer Re-
search, vol. 79, no. 6, pp. 1239–1251, 2019.
[102] L. Dzikowski, R. Mirzaei, and S. Sarkar et al., “Fibrinogen in the
glioblastoma microenvironment contributes to the invasiveness of brain
tumor-initiating cells,” Brain Pathology, vol. 31, no. 5, p. e12947, 2021.
[103] B. Coquerel, F. Poyer, and F. Torossian et al., “Elastin-derived peptides:
matrikines critical for glioblastoma cell aggressiveness in a 3-D system,”
Glia, vol. 57, no. 16, pp. 1716–1726, 2009.
[104] J. M. Ross, C. Kim, and D. Allen et al., “The expanding cell diversity
of the brain vasculature,” Frontiers in Physiology, vol. 11, 2020.
[105] J. Guyon, C. Chapouly, and L. Andrique et al., “The normal and
brain tumor vasculature: morphological and functional characteristics
and therapeutic targeting,” Frontiers in Physiology, vol. 12, p. 622615,
2021.
[106] H. Kadry, B. Noorani, and L. Cucullo, “A blood–brain barrier overview
on structure, function, impairment, and biomarkers of integrity,” Fluids
and Barriers of the CNS, vol. 17, no. 1, p. 69, 2020.
[107] Z. Zhao, A. R. Nelson, and C. Betsholtz et al., “Establishment and
dysfunction of the blood-brain barrier,” Cell, vol. 163, no. 5, pp. 1064–
1078, 2015.
[108] P. S. Steeg, “The blood–tumour barrier in cancer biology and therapy,”
Nature Reviews Clinical Oncology, vol. 18, no. 11, pp. 696–714, 2021.
[109] M. D. Sweeney, A. P. Sagare, and B. V. Zlokovic, “Blood–brain barrier
breakdown in Alzheimer disease and other neurodegenerative disorders,”
Nature Reviews Neurology, vol. 14, no. 3, pp. 133–150, 2018.
[110] E. Belykh, K. V. Shaffer, and C. Lin et al., “Blood-brain barrier, blood-
brain tumor barrier, and fluorescence-guided neurosurgical oncology: de-
livering optical labels to brain tumors,” Frontiers in Oncology, vol. 10,
p. 739, 2020.
[111] M. D. Sweeney, Z. Zhao, and A. Montagne et al., “Blood-brain barrier:
from physiology to disease and back,” Physiological Reviews, vol. 99,
no. 1, pp. 21–78, 2019.